STOCK TITAN

Medline Inc. (MDLN) SEC Filings, Jan 8, 2026

MDLN NASDAQ
Rhea-AI Summary

Medline Inc. (MDLN) director Stephen H. Wise filed an initial Form 3 beneficial ownership report following an event dated 12/17/2025. In this filing, he indicates that no Medline securities are beneficially owned, and both the non-derivative and derivative securities tables show no holdings. The form is filed by one reporting person in his capacity as a director, providing a baseline disclosure of his current ownership status.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Medline Inc. director Robert R. Schmidt filed an initial insider ownership report in connection with an event dated 12/17/2025. This filing states that he currently has no securities beneficially owned in Medline Inc., meaning he does not report owning any Medline common stock or derivative securities at this time. The form is filed by a single reporting person and reflects his status solely as a director, not as an officer or 10% owner.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Medline (MDLN) SEC filings are available on StockTitan?

StockTitan tracks 92 SEC filings for Medline (MDLN), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Medline (MDLN)?

The most recent SEC filing for Medline (MDLN) was filed on January 8, 2026.